The clinical approach involving the strategic monitoring and modification of dehydroepiandrosterone (DHEA) levels, which serves as a crucial steroid hormone precursor for both androgens and estrogens. Effective management aims to maintain DHEA and its sulfate ester, DHEA-S, within a healthy physiological range to support adrenal function, immune competence, and overall hormonal balance. This management is especially important as endogenous production declines with advancing age.
Origin
DHEA was isolated in the 1930s, and its role as a key steroidogenic precursor, synthesized primarily by the adrenal cortex, has been understood within endocrinology for decades. The term ‘management’ emphasizes a controlled, clinical oversight of its therapeutic use or supplementation to avoid supraphysiological levels.
Mechanism
The mechanism relies on DHEA’s conversion in peripheral tissues into more potent sex steroids, such as testosterone and estradiol, via specific enzymes like 3β-hydroxysteroid dehydrogenase. Clinical management involves administering DHEA to replenish declining levels, thereby providing the necessary substrate for the body to synthesize its own active hormones on demand, acting as a crucial intermediary in the steroid cascade.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.